🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Stem cell transplantation and blood product transfusions are standard of ca...
Status
Completed
Location
Antwerp University Hospital (UZA)
Start Date
2009-11-01
Trial ID
NCT06267898
This phase II MyeloMATCH treatment trial compares the effect of adding vene...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-17
Trial ID
NCT06954987
Treatments Being Tested
This trial will test the hypothesis that the combination of sirolimus, myco...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2007-10
Trial ID
NCT00548717
Treatments Being Tested
Women undergoing myeloablative allogeneic hematopoietic cell transplant (MA...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-07
Trial ID
NCT01343368
Treatments Being Tested
This research study investigates the benefits and possible risks of adding ...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2009-03
Trial ID
NCT00639717
This Phase 2, single-arm, open-label study aims to evaluate the safety and ...
Status
Recruiting
Location
Penn State Cancer Institute
Start Date
2026-03-09
Trial ID
NCT06926595
Treatments Being Tested
This phase I/II trial studies the side effects of giving reduced-intensity ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2002-10
Trial ID
NCT00054353
In this trial dose reduced conditioning is compared to standard conditionin...
Status
Terminated
Location
University Hospital
Start Date
2004-05
Trial ID
NCT01203228
Treatments Being Tested
The investigators intend to utilize reduced intensity conditioning and allo...
Status
Terminated
Location
New York Medical College
Start Date
2013-01
Trial ID
NCT01636388
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Zevalin...
Status
Completed
Location
Service d'hématologie - CHU de Besançon
Start Date
2008-02
Trial ID
NCT00607854
Treatments Being Tested